gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (žr. 5 skyrių.
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)